EDGAR Filing Documents for 0001288123-10-000073

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001288123-10-000073

Filing Date

2010-10-28

Accepted

2010-10-28 14:58:14

Documents

Period of Report

2010-10-26

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4
1	PRIMARY DOCUMENT	primary_doc.xml	4	4914
	Complete submission text file	0001288123-10-000073.txt		6688

Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010

Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTIGENICS INC. 3 FORBES RD LEXINGTON MA 02421

Business Address

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 101147704